Abstract:Abstract Studies of radiation interaction with tumor cells often take apoptosis as the desired results. However, mitotic catastrophe and senescence are also promoted by clinically relevant doses of radiation. Furthermore, p53 is a well-known transcription factor that is closely associated with radiosensitivity and radiation-induced cell death. Therefore, we aimed to investigate the involvement of radiosensitivity, cell death modalities and p53 status in response to carbon-ion radiation (CIR) here. Isogenic human colorectal cancer cell lines HCT116 (p53 +/+ and p53 −/− ) were irradiated with high-LET carbon ions. Cell survival was determined by the standard colony-forming assay. 53BP1 foci were visualized to identify the repair kinetics of DNA double-strand breaks (DSBs). Cellular senescence was measured by SA-β-Gal and Ki67 staining. Mitotic catastrophe was determined with DAPI staining. Comparable radiosensitivities of p53 +/+ and p53 − /− HCT116 colorectal cells induced by CIR were demonstrated, as well as persistent 53BP1 foci indicated DNA repair deficiency in both cell lines. Different degree of premature senescence in isogenic HCT116 colorectal cancer cells suggested that CIR-induced premature senescence was more dependent on p21 but not p53. Sustained upregulation of p21 played multifunctional roles in senescence enhancement and apoptosis inhibition in p53 +/+ cells. p21 inhibition further increased radiosensitivity of p53 +/+ cells. Complex cell death modalities rather than single cell death were induced in both p53 +/+ and p53 − /− cells after 5 Gy CIR. Mitotic catastrophe was predominant in p53 − /− cells due to inefficient activation of Chk1 and Chk2 phosphorylation in combination with p53 null. Senescence was the major cell death mechanism in p53 +/+ cells via p21-dependent pathway. Taken together, p21-mediated premature senescence might be used by tumor cells to escape from CIR-induced cytotoxicity, at least for a time.

Variable Sensitivity to DNA Damaging Chemotherapeutic Modulated by Cell Type-Dependent Bimodal P53 Dynamics

Cell Type–dependent Bimodal P53 Activation Engenders a Dynamic Mechanism of Chemoresistance

DNA Damage Strength Modulates a Bimodal Switch of P53 Dynamics for Cell-Fate Control

Cell Fate Decision by an Adaptable Molecular Timer of P53

Mathematical Model Identifies Effective P53 Accumulation with Target Gene Binding Affinity in DNA Damage Response for Cell Fate Decision

Modeling the Role of P53 Pulses in DNA Damage- Induced Cell Death Decision

The Combination Of Pulsatile And Switch-Like Behaviors Of P53 In Response To Dna Damage

Two-phase Dynamics of P53 in the DNA Damage Response

A Plausible Model for Bimodal P53 Switch in Dna Damage Response

An EZH2-mediated Epigenetic Mechanism Behind P53-Dependent Tissue Sensitivity to DNA Damage.

Differential gene expression in cells with different p53 mutations identifies genome-wide p53 targets and shows distinct modulation of cellular pathways in response to DNA damage

p53 dynamics vary between tissues and are linked with radiation sensitivity

P53 Dynamics Orchestrates with Binding Affinity to Target Genes for Cell Fate Decision

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Cell Fate Decision Mediated by P53 Pulses

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

A Two-Step Mechanism For Cell Fate Decision By Coordination Of Nuclear And Mitochondrial P53 Activities

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

Towards the Overcoming of Anticancer Drug Resistance Mediated by P53 Mutations

The Different Regulatory Effects of P53 Status on Multidrug Resistance Are Determined by Autophagy in Ovarian Cancer Cells

Dynamic Regulation of P-TEFb by 7SK Snrnp is Integral to the DNA Damage Response to Regulate Chemotherapy Sensitivity.